SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001615774-18-002846
Filing Date
2018-04-24
Accepted
2018-04-24 12:35:08
Documents
1
Period of Report
2018-03-02

Document Format Files

Seq Description Document Type Size
1 3 s109765_form3.html 3  
1 3 s109765_form3.xml 3 3007
  Complete submission text file 0001615774-18-002846.txt   4486
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address PO BOX MUENSTEREIFELER ST. COLOGNE 2M 50937
Business Address
Velden Claus Vander (Reporting) CIK: 0001733908 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37606 | Film No.: 18770822